共 50 条
- [1] Management of L-Dopa Overdose in the Competitive Inhibition State (Expression of Concern of Vol 6, Pg 93, 2014) [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2020, 12 : 59 - 59
- [3] RETRACTION: Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review (Retraction of Vol 6, Pg 107, 2014) [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 39 - 39
- [4] RETRACTION: Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia (Retraction of Vol 6, Pg 189, 2014) [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 43 - 43
- [5] RETRACTED: Management of L-dopa overdose in the competitive inhibition state (Publication with Expression of Concern. See vol. 12, pg. 59, 2020) (Retracted article. See vol. 12, pg. 271, 2020) [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2014, 6 : 93 - 99
- [8] RETRACTION: a The Parkinson's Disease Death Rate: Carbidopa and Vitamin B6 (Retraction of Vol 6, Pg 161, 2014) [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 41 - 41